Literature DB >> 3129841

Cyclosporine potentiates the immunosuppressive effects of anti-interleukin 2 receptor monoclonal antibody therapy.

J W Kupiec-Weglinski1, H J Hahn, R L Kirkman, H D Volk, A Mouzaki, R DiStefano, G Tellides, M Dallman, P J Morris, T B Strom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3129841

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

Review 1.  Daclizumab: a review of its use in the prevention of acute rejection in renal transplant recipients.

Authors:  L R Wiseman; D Faulds
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

2.  Comparative in vitro study of the immunomodulatory activity of humanized and chimeric anti-CD25 monoclonal antibodies.

Authors:  B Kircher; K Lätzer; G Gastl; D Nachbaur
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

3.  Cardiac allograft survival in mice treated with IL-2-PE40.

Authors:  H Lorberboum-Galski; L V Barrett; R L Kirkman; M Ogata; M C Willingham; D J FitzGerald; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 12.779
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.